ELCRX
Price
$38.89
Change
-$0.04 (-0.10%)
Updated
May 30 closing price
Net Assets
384.94M
GAFFX
Price
$77.55
Change
+$0.55 (+0.71%)
Updated
Jun 2 closing price
Net Assets
301.73B
Interact to see
Advertisement

ELCRX vs GAFFX

Header iconELCRX vs GAFFX Comparison
Open Charts ELCRX vs GAFFXBanner chart's image
Eaton Vance Growth R
Price$38.89
Change-$0.04 (-0.10%)
VolumeN/A
Net Assets384.94M
American Funds Growth Fund of Amer F3
Price$77.55
Change+$0.55 (+0.71%)
VolumeN/A
Net Assets301.73B
ELCRX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ELCRX vs. GAFFX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELCRX is a Buy and GAFFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 302B vs. ELCRX (385M). GAFFX pays higher dividends than ELCRX: GAFFX (0.65) vs ELCRX (0.00). ELCRX was incepted earlier than GAFFX: ELCRX (16 years) vs GAFFX (8 years). ELCRX (1.28) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. ELCRX (18.00). ELCRX has a lower initial minimum investment than GAFFX: ELCRX (1000) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. ELCRX (7.82). GAFFX return over 5 years is better than : 48.56 vs. ELCRX (38.40).
ELCRXGAFFXELCRX / GAFFX
Total Expense Ratio1.280.30427%
Annual Report Gross Expense Ratio1.280.30427%
Fund Existence16 years8 years-
Gain YTD0.1803.3975%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets385M302B0%
Annual Yield % from dividends0.000.65-
Returns for 1 year7.829.7480%
Returns for 3 years33.3736.5791%
Returns for 5 years38.4048.5679%
Returns for 10 years75.65N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTTA0.970.03
+3.19%
Pasithea Therapeutics Corp
BIP33.110.45
+1.38%
Brookfield Infrastructure Partners LP
SMWB7.420.01
+0.13%
Similarweb Ltd
ACRS1.46N/A
N/A
Aclaris Therapeutics
CRNX30.51-0.01
-0.03%
Crinetics Pharmaceuticals